Inmune Bio's total assets for Q2 2026 were $26.84M, an increase of 3.98% from the previous quarter. DE:0Y2 total liabilities were $6.48M for the fiscal quarter, a 4.67% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.